Benzinga's Top #PreMarket Gainers
Uniqure NV (NASDAQ: QURE) shares climbed 13.80 percent to $38.02 in pre-market trading following Saturday announcement of positive topline results from Phase I/II trial in Sanfilippo B syndrome patients using AAV5-based gene therapy.
AcelRx Pharmaceuticals Inc (NASDAQ: ACRX) shares rose 9.57 percent to $4.35 in pre-market trading after PDL BioPharma Inc (NASDAQ: PDLI) announced the acquisition of portion of AcelRx Pharma's expected royalties and milestones from Zalviso for $65 million.
Allot Communications Ltd (NASDAQ: ALLT) gained 7.14 percent to $5.25 in pre-market trading after the company reported that it has received an $8 million expansion order from a tier-1 operator.
Shire PLC (ADR) (NASDAQ: SHPG) shares jumped 3.93 percent to $227.09 in pre-market trading following announcement of EC approval of non-stimulant ADHD treatment.
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.